Astra Zeneca becomes controversial after missteps Astra Zeneca has likely produced a safe and effective COVID-19 vaccine in only 9 months, a significant achievement that could help end the pandemic, reported CNN.
But missteps along the way have led to criticism from both policymakers and health officials.
The drug maker mistakenly gave some volunteers only half a dose of the vaccine in clinical trials.
The company has also been criticized for omitting crucial information from public statements.
U.S. regulators have questioned the accuracy of Astra Zeneca vaccine data, saying it didn?t include the most recent data.
Additionally, severe production delays in Europe have created a political fire storm and breakdown in relations with EU leaders.
?[They are] over promising and under delivering by massive amounts, we all see that they have bundled up at least twice their test data,? Philippe Lamberts, a member of the European Parliament, told the BBC?s ?Today Programme,? reported the Express. ?So everything points to a company that cannot be relied upon.?
Meanwhile, the National Institute of Allergy and Infectious Diseases (NIAID) expressed concerns that Astra Zeneca presented ?outdated? data from a trial of the vaccine?s effectiveness.
It would be a good way to stop the Yanks and EU from demanding it and more for us.